Price $2.45 |
Market Cap
302.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
0.02
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
301K
|
FCF
-1.5
|
|
Op. Margin
1.40%
|
Net Margin
-6.40%
|
ROE
66.70%
|
ROI
2.10%
|
|
ROA
-5.40%
|
EPS Growth
61.80%
|
Current Ratio
1.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Champions Oncology Inc (CSBR) | $7.96 | - | - | 90.7M | Strong Buy |
| PDL BioPharma Inc (PDLI) | $3.13 | - | - | 355.9M | Strong Buy |
| TearLab Corp (TEAR) | $0.07 | - | - | 900K | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.29 | - | - | 12.6M | Strong Buy |
| Delcath Systems, Inc. (DCTH) | $0.08 | - | - | 2.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
